Analgesia with intra-articular bupivacaine in total hip arthroplasty .
Intra-articular bupivacaine reduces postoperative pain and meperidine use after total hip arthroplasty: a randomized, double-blind study
J Arthroplasty. 2014 Dec;29(12):2457-6196 patients scheduled for total hip arthroplasty were randomized to an intra-articular injection of either 300mg bupivacine or saline as part of their multimodal postoperative analgesia regimen. The purpose of this study was to determine the efficacy of an IA injection of bupivacaine on reducing postoperative pain. Postoperative pain and meperidine consumption (used for pain in excess of 40mm on a 100mm VAS) were assessed over the first 72 postoperative hours. Results demonstrated significantly lower pain within the IA-bupivacaine group compared to placebo saline group, as well as reduced meperidine use in the first 24 postoperative hours.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
